Actos (pioglitazone) is a prescription tablet used to treat type-2 diabetes. It works by making cells more sensitive to insulin, a hormone produced by …
Actos drug-maker Takeda Pharmaceuticals, Asia’s biggest drug manufacturer, faces up to 10,000 lawsuits that charge …
During the Actos clinical trials, nearly 10,000 type-2 diabetes patients were treated with the drug. The trials showed…
Although Actos first hit the prescription drug market in 1999, there is mounting evidence of a link between…
When the oral diabetes drug Actos was released to the market in 1999, it was lauded as a…
Even though the oral type 2 diabetes drug Actos (pioglitazone) has been linked to bladder cancer, heart failure and blindness, federal drug regulators have been slow to put the brakes…
With mounting evidence that the type 2 diabetes drug Actos has a direct link to…
Since 1999, type 2 diabetes patient have been prescribed Actos in an effort to get…